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Microevolution of Campylobacter 
jejuni during long-term infection in 
an immunocompromised host
clare R. Barker1,2,3, Anaïs painset2,3, Craig Swift2, Claire Jenkins2,3, Gauri Godbole  2, 
Martin c. J. Maiden  1,3 & timothy J. Dallman2,3,4 ✉
Campylobacteriosis typically manifests as a short-lived, self-limiting gastrointestinal infection in 
humans, however prolonged infection can be seen in cases with underlying immunodeficiency. Public 
Health England received 25 isolates of Campylobacter jejuni from an individual with combined variable 
immunodeficiency over a period of 15 years. All isolates were typed and archived at the time of receipt. 
Whole genome sequencing (WGS) and antimicrobial susceptibility testing were performed to examine 
the relatedness of the isolates and to investigate the changes in the genome that had taken place 
over the course of the infection. Genomic typing methods were compared to conventional phenotypic 
methods, and revealed that the infection was caused by a single, persistent strain of C. jejuni belonging 
to clonal complex ST-45, with evidence of adaptation and selection in the genome over the course of the 
infection. Genomic analysis of sequence variants associated with antimicrobial resistance identified the 
genetic background behind rRNA gene mutations causing variable levels of resistance to erythromycin. 
This application of WGS to examine a persistent case of campylobacteriosis provides insight into 
the mutations and selective pressures occurring over the course of an infection, some of which have 
important clinical relevance.
Campylobacter species, principally Campylobacter jejuni (~90% of cases) and Campylobacter coli (~10% of cases), 
are the most common cause of bacterial gastroenteritis in the United Kingdom1. Human infection is largely 
acquired through consumption or handling of contaminated poultry meat2. Campylobacteriosis in otherwise 
healthy persons is a self-limiting disease, which typically lasts less than ten days and rarely requires antibiotic 
therapy. In immunocompromised cases the disease can however be more severe and despite treatment, may 
persist for long periods of time.
The immune response to Campylobacter infection is mediated by a combination of adaptive and innate 
responses3, with defects in these processes, such as primary immunodeficiencies or Human Immunodeficiency 
Virus (HIV) infection, linked to more severe or prolonged disease4. As well as an increased likelihood of seri-
ous complications including bacteraemia, these patients may also develop recurrent infections5 and some-
times chronic carriage of Campylobacter despite antibiotic treatment. Reported cases of chronic infection with 
Campylobacter in patients with hypogammaglobulinaemia, an immune disorder resulting in a reduction of 
gamma globulins, range from several months6–8 to six years9 with additional reports of potential cases lasting for 
17 years10 and 25 years11. The return of a C. jejuni infection following antibiotic treatment in an immunocom-
petent patient has been described12. The majority of these long-term studies of Campylobacter carriage have not 
ascertained whether these cases are due to an initial infection, and subsequent colonisation with a single popula-
tion of bacteria, or if they are the result of multiple, repeated infections. A PCR-based method determined that a 
16-month infection in a patient with hypogammaglobulinaemia was the result of two strains of C. jejuni: a tran-
sient strain and a persistent strain13. The authors of this study concluded that their method was not suitable for 
examining clonal patterns over extended periods of time. Utilising whole genome sequencing (WGS) technology, 
it is possible to examine the relatedness of isolates to single nucleotide resolution and therefore track changes in 
the bacterial genomes over the course of the host’s infection. This has been highlighted by a study which examined 
the colonisation of a human host by a single strain of C. jejuni, categorising its evolution and adaptation14.
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Within-host population genetics and microevolution are important emerging areas of microbiology, which 
are accessible by WGS studies, and there have been several reports examining the evolution of single clones 
of bacteria within the same host over several years14–19. Bacterial infections in immunocompromised patients 
are particularly interesting as they present an environment with altered immune selection, and allow long-term 
growth in a stable setting. At the time of writing, study of long-term within-host microevolution in immuno-
compromised patients had been examined in very few bacterial species14,20. Much of the difficulty lies in gaining 
access to a viable collection of patient isolates that have been gathered over a long period of time.
The Gastrointestinal Bacteria Reference Unit (GBRU) at Public Health England (PHE) receives human 
isolates of Campylobacter spp. for species identification, typing and antimicrobial susceptibility testing. All 
isolates received are archived in frozen storage, providing a unique opportunity to examine isolates that are rel-
evant to public health and which have been collected over time. Here, WGS was applied to a collection of 25 
Campylobacter jejuni isolates received by GBRU over the course of a 15-year infection in a case with combined 
variable immunodeficiency (CVID). The relatedness of these isolates, their population structure and analyses of 
the changes that have occurred over time, particularly in relation to antibiotic resistance, are described.
Results
Sequence typing. To determine the genetic relatedness between the isolates, sequence typing was per-
formed at three levels of resolution. 7-gene MLST revealed that all but one of the isolates belong to ST-45, except 
isolate 18857 (ST-7334), which differed by a single nucleotide in uncA (Fig. 1). All isolates however belonged to 
the ST-45 clonal complex. Ribosomal sequence typing (rMLST), which targets the 52 genes that encode ribo-
somal proteins in Campylobacter21,22, identified variation at three loci: rpsA, rpsJ, and rpsR – encoding the 30 S 
ribosomal proteins S1, S10 and S18 respectively (Supplementary Table S1). The mutation in rpsJ was identified 
in isolates 236133 and 18857, and the mutation in rpsR was identified in isolate 236136. A 3-base TAG insertion 
in rpsA was initially identified in isolate 236133 and was subsequently detected in every isolate thereafter (Fig. 1, 
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Figure 1. Phylogenetic analysis of the isolates revealed a ladder-like tree. SNP-based maximum-likelihood 
phylogeny of the core genome, rooted on the oldest isolate. The tips are coloured according to the date of 
isolation, and sequence typing results are displayed to the left. ST, sequence type; rST, ribosomal sequence type; 
SNP, single nucleotide polymorphism.
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Supplementary Table S1). Variation was also quantified across the 1,343 loci defined by the core genome sequence 
typing (cgMLST) C. jejuni and C. coli scheme23. The isolates within this study were found to vary at 104 (7.7%) of 
these loci, which included the three variable rMLST loci (Supplementary Table S2). Isolate 18857 that was a single 
locus variant by MLST was subsequently identified to vary by only 4 cgMLST loci from the next closest isolate, 
excluding incomplete loci.
Root-to-tip & temporal analyses. The population structure of the isolates was investigated phylogenet-
ically based on nucleotide variation across a core genome alignment (Fig. 1). A root-to-tip regression analysis 
was performed to assess the presence of a temporal signal (Fig. 2). A strong correlation was observed between 
isolation date and branch length (R2 = 0.915, correlation coefficient = 0.967) consistent with a constant accrual 
of diversity over the course of infection. The best-fitting root was isolate 236126 (January 2002) and the estimated 
time to most recent common ancestor was October 1996. The mutation rate was estimated to be 1.75e−6 substitu-
tions per site per year. A similar rate of mutation based on a genome size of 1,641,481 bp24 was determined using 
Bayesian temporal analysis: 2.07e−6 subs per site per year, 95% CI = 1.56e−6–2.59e−6.
Microevolution during colonisation. Of the 104/1,343 cgMLST loci that were found to be variable within 
the patient’s isolates, 62 (59.6%) were sporadic, with an allele change occurring in three or fewer isolates with no 
obvious inheritance (Supplementary Table S2). In the remaining 42 loci, alleles occurred and became fixed after 
different time points, appearing in the majority of isolates after that time (Fig. 3). Of these 42 loci, 15 (35.7%) also 
had sporadic mutations (Fig. 3, Supplementary Table S2).
The 42 loci at which this ‘fixed’ typed of allelic variation occurred were investigated further; over three-quarters 
(83%) of these had accumulated non-synonymous mutations. In 11/42 alleles (26.2%) a frameshift had occurred 
due to an indel, which were also identified in 23 (37.1%) of the alleles containing sporadic mutations. In total, 
almost two-thirds (31/104, 29.8%) of all the variable core loci were affected by frameshift mutations over the 
course of the infection.
comparison with previous isolates. A previously published study also investigated the adaptation of 
a single clone of C. jejuni ST-45 in an immunocompromised patient14. We downloaded the genomes from this 
study and performed our workflow of sequence typing, temporal analysis and microevolution analysis upon 
these isolates, to investigate the reproducibility of the results shown here. The results showed a similarly-shaped 
phylogeny (Fig. 4), root-to-tip linear regression data (slope = 2.96e−2, R2 = 0.9801, correlation coefficient = 0.99), 
and mutation rate (5.55e−6). Additionally, there were a similar number of fixed mutations (33 loci), whilst not the 
same loci as identified in this study many also occurred in genes encoding cell surface structures such as capsular 
polysaccharide proteins and flagellae, as well as chemotaxis proteins (Supplementary Table S3).
Antibiotic resistance. All isolates displayed resistance to ciprofloxacin and nalidixic acid, with MIC 
values ranging from 4 mg/l to>32 mg/l for ciprofloxacin and from 64 mg/l to>512 mg/l for nalidixic acid 
(Supplementary Table S4). The phenotypic resistance to fluoroquinolones was conferred by the presence of two 
mutations in the quinolone resistance determining region (QRDR) of gyrA (257 C > T and 268 G > A) resulting 
in amino acid substitutions Thr86Ile and Asp90Asn.
Figure 2. Root-to-tip analysis identified a temporal signal in the genomic data. (A) Phylogenetic tree with the 
best-fitting root, as determined by TempEst software61, tips coloured according to date of isolation. (B) Root-to-
tip linear regression plot showing date of isolation versus branch length. Slope = 2.26e−2, TMRCA = 1996.75, 
R2 = 0.915, correlation coefficient = 0.957. Blue branches represent points below the regression line, indicating 
sequences that are less divergent (for their sampling date) than average. Red branches represent the opposite 
situation.
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Phenotypic resistance to erythromycin was variable over the course of the infection (Fig. 5). The first four iso-
lates received (September 2001 – March 2002) were susceptible, until 236126 (July 2002) which exhibited a high 
level of resistance (MIC > 512 mg/l). Resistance in this isolate was caused by a 2075 A > G transition in each of the 
three copies of the 23 S rRNA gene (Fig. 5, Table 1). Subsequent isolates did not carry any 23 S mutation and were 
phenotypically susceptible until July 2012, when isolate 236137 exhibited high level resistance (MIC > 512 mg/l). 
For this isolate the resistance was conferred by a 2074 A > C transversion in all three copies of the 23 S rRNA gene. 
Subsequent isolates however, only carried the 2074 A > C mutation in one of the three copies. The single mutated 
copy of the 23 S rRNA gene was maintained until April 2015, and the MIC values between these dates varied 
between 0.25 mg/l and 16 mg/l.
Discussion
While there exist numerous studies examining how bacteria vary over time at the population level, there are 
relatively few on how bacteria differ within a single host throughout an infection presumably due to the often 
transient nature of colonisation during infection and relatively slow mutation rate of bacteria.. Consequently, 
within-host studies of bacteria typically involve chronic pathogens such as Mycobacterium tuberculosis18,25,26 and 
Helicobacter pylori15,16. Immunodeficient patients with persistent infections can provide an opportune environ-
ment for studying the evolution of bacteria with normally shorter infection cycles. Here, we have examined the 
microevolution that occurred in a single clone over the course of a fifteen-year case of campylobacteriosis; where 
the pathogen in question is typically cleared within two weeks. By performing genomic analyses on this collection 
Figure 3. Acquisition and fixation of mutations over time in 42 loci. Tree topology and colouring as in Fig. 1.
Figure 4. Phylogenetic analysis of the comparison isolates14 revealed a similar, ladder-like tree. SNP-based 
maximum-likelihood phylogeny of the core genome, rooted on the oldest isolate. The tips are coloured 
according to the date of isolation. SNP, single nucleotide polymorphism.
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Figure 5. Erythromycin MIC values of isolates and corresponding 23 S rRNA gene mutations. Red line 
represents the EUCAST breakpoint value. Icons identify the number of copies of the 23 S rRNA gene that have 
acquired a mutation in each isolate. MIC, minimum inhibitory concentration.
Isolate
Number of 
reads covering 
position 2074
Number 
of reads 
mapping to A
Percent 
of reads 
mapping to A
Mutation (if 
present)
23 S rRNA 
copies 
mutated
MIC 
(mg/l)
236124 1,359 1,348 99.19% — 4
236125 2,310 2,284 98.87% — 2
236126a 1,592 5 0.31% 99.37% A > G 3 512*
236127 1,749 1,739 99.43% — 4
236128 1,776 1,767 99.49% — 2
236129 1,555 1,547 99.49% — 2
236130 1,913 1,896 99.11% — 4
236131 1,529 1,520 99.41% — 2
236132 1,760 1,752 99.55% — 4
236133 1,924 1,902 98.86% — 2
236123 1,267 1,261 99.53% — 4
236134 2,913 2,899 99.52% — 2
236136 2,081 2,068 99.38% — 1
236137 1,542 8 0.52% 99.42% A > C 3 512*
18857 591 390 65.99% 32.99% A > C 1 16*
236139 2,097 1,366 65.14% 34.29% A > C 1 16*
56946b 1,743 1,167 66.95% 32.99% A > C 1 —
74288 2,268 1,606 70.81% 29.10% A > C 1 2
74289 2,367 1,488 62.86% 37.14% A > C 1 0.25
85702 1,024 648 63.28% 36.52% A > C 1
4
8*
106535b
1,349 926 68.64% 31.13% A > C 1 —
1,827 1,131 61.90% 38.04% A > C 1 —
201487 2,258 2,256 99.91% — 0.25
216332 1,774 1,770 99.77% — 1
Table 1. Reads covering the 23 S rRNA gene, mutations at position 2074 and corresponding phenotype. Isolates 
U1 and U2 could not be regrown from frozen storage therefore no genotype was available for these isolates. 
aThe results are for position 2075. bIsolates were sequenced upon receipt but could not be regrown from frozen 
storage and so genotypic but not phenotypic results were available for these isolates. Asterisks indicate MIC 
values corresponding with resistance to erythromycin. MIC, minimum inhibitory concentration.
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of serially sampled isolates we have gained insight into how this population of C. jejuni has evolved over the 
course of infection in an environment with reduced immune selection.
The isolates obtained are closely related and form a single population consistent with a single founding strain 
effectively colonising the gut of the patient. This finding suggests that serotyping is not a robust marker of clonal-
ity in Campylobacter. Phylogenetic analysis identified a strong temporal signal with respect to the accumulation 
of mutations. The mutation rate of this population was estimated to be 2.07e−6 per site, which approximates to 
3.5 mutations in the genome each year. The SNP variation across the isolates suggests that, whilst there is a sin-
gle dominant strain persisting within this individual, there were sub-clones being sampled at the different time 
points, leading to the multiple sub-clades within the reconstituted phylogeny. This dominant strain can be seen in 
the backbone of all the phylogenetic trees (Figs. 1–3), which are ladder-like in nature.
A six year gap between samples was observed between 2005 and 2011where no isolates were sent to the ref-
erence laboratory for typing from this patient. We are unable to say if the patient was symptomatic or not during 
this period or if isolates were not sent for another reason (Campylobacter isolates are sent to the reference labo-
ratory voluntarily from diagnostic laboratories in the UK). Whilst we cannot unequivocally state this is a single 
infection throughout the time series as opposed to a secondary infection by a genetically similar strain we feel the 
former is the most plausible explanation based on the genome sequences for the following reasons (a) The level of 
relatedness between 2001–2005 and 2011–2016 strains is consistent with a steady accrual of variation in-line with 
the strong regression seen in root-to-tip divergence (b) The fact that the 2011–2016 diversity is descendant of the 
diversity seen in 2001–2005 supports a continual evolution of a strain in a closed system.
To examine the genes that have changed over the course of the infection the 1,343 loci within the C. jejuni 
cgMLST scheme were examined. Of those that were variable, over one third were present in all subsequent isolates 
and over half were non-synonymous changes, and so plausibly sites under selection. Despite the immunocom-
promised status of the patient, many of the proteins encoded by these loci are located on the bacterial cell surface, 
consistent with selection caused by the host immune system. These indications of host-pathogen selection and 
the phylogenetic laddering, hallmark of directional selection, suggest this population may have been under strong 
diversifying selection from host responses. Given the immunocompromised status of the patient, other evolution-
ary mechanisms, such as population bottlenecks, may also be responsible for the changes seen during the infec-
tion. It has been proposed that in situations where immune selection is absent, non-selective population dynamic 
process such as genetic bottlenecks could produce temporal clustering in a phylogenetic tree27,28. It is likely that 
any such bottleneck was small, leading to a shift in the prevalence of certain variants, as larger bottleneck sizes in 
C. jejuni have been shown to maintain population diversity29. This potential bottleneck may have been caused by 
any number of reasons, including: antibiotic or immunotherapy treatment; competition from the surrounding 
microbiota or a local co-infection; or a change in environmental conditions such as reduced nutrients.
Over one quarter of the fixed non-synonymous mutations were frameshift mutations caused by indels, along-
side more than one third of the sporadic mutations. As the genome of C. jejuni is known to contain ‘at least 
twenty’ pseudogenes24, the formation of an additional thirty pseudogenes over fifteen years is notable. Based on 
the 1,343 loci in the cgMLST scheme of C. jejuni23, these 31 pseudogenes translate to ~2.3% of the core protein 
coding capacity. This is far lower than the 300 genes (~6.9%) reported in a study which investigated a 15-year 
Salmonella enterica Enteritidis infection in an immunocompromised patient20. In their case however, the causa-
tive organism was a mutS mutant, with a possible 1,000-fold increased rate of frameshift mutations. Considering 
the different protein encoding capacities of the two species (1,343 versus 4,347 genes) as well as the increased 
frameshift rate of the S. Enteritidis isolates, this is consistent with a deletional bias in the C. jejuni isolates. The 
deletional bias may be the result of a lack of selection, which would otherwise be driven by the immune system, or 
ineffective selection due to a small population size. A small population size is consistent with there being repeated 
population bottlenecks, as was suggested by the phylogenetic data. The high frequency of pseudogene formation 
resulting from the lack of selective pressure against deletional mutations may additionally be evidence of host 
adaptation and genome degradation occurring on a reduced timescale, as was observed by Klemm et al.20.
A similar study looking at the genomics of long-term campylobacteriosis in an immunocompromised patient 
also, interestingly, involved a strain of ST-45 C. jejuni14. We compared the rate and type of microevolutionary 
events in this dataset of isolates with those from this study. The results confirm our conclusions; that there is a 
strong molecular clock signal and that within-host microevolution of C. jejuni leads to non-synonymous muta-
tions that become fixed within the population. many of which may affect cell surface proteins. The analysis of this 
additional dataset also supports our findings on the calculated mutation rate of C. jejuni, and correlates well with 
the estimated value by Wilson et al.30. Additionally, other studies investigating isolates from single patients have 
also found mutations in similar genes, such as the motility accessory factor family and chemotaxis proteins22,31, 
lending support to the hypothesis that this is a regular occurrence within C. jejuni genomes during infection.
Previous studies of the passage of C. jejuni through animal and human hosts have revealed the occurrence of 
mutations in homopolymeric tracts of contingency loci, with frameshift mutations in genes regulating surface 
structure biosynthesis32,33. While we detected multiple alleles in eleven of the contingency loci detailed by Jerome 
et al.32 (Supplementary Table S5), these were all sporadic mutations and did not appear to become fixed within the 
population, but reinforced that these loci are mutation hotspots.
Antibiotic resistance in Campylobacter is a major clinical and public health concern, with the World Health 
Organisation adding fluoroquinolone-resistant Campylobacter to its 2017 global priority list of antibiotic resistant 
pathogens deemed to pose the greatest threat to human health34. In cases where treatment is required, such as in 
immunocompromised patients where infection is likely to be more severe, the two most commonly prescribed 
antibiotics for campylobacteriosis are erythromycin and ciprofloxacin. Within this collection of isolates, we found 
resistance to both antibiotics, with phenotypic data supporting the presence of previously characterised single 
point mutations.
7Scientific RepoRtS |        (2020) 10:10109  | https://doi.org/10.1038/s41598-020-66771-7
www.nature.com/scientificreportswww.nature.com/scientificreports/
Quinolone resistance has been described in C. jejuni for over 25 years, arising shortly after the introduction of 
fluoroquinolones for veterinary use35,36 and increasing in prevalence over time37. It is unusual that two mutations 
(Thr86Ile and Asp90Asn) are present in every isolate in this study, as most fluoroquinolone resistance in C. jejuni 
is the result of a single mutation in gyrA38–41. As previously described, the Thr86Ile mutation is associated with 
high level resistance (≥16 mg/l) to ciprofloxacin, lower levels of resistance are caused by the Asp90Asn mutation 
(≤8 mg/l), and the presence of both results in the highest level of resistance (≥128 mg/l)42,43. This high-level, 
stable resistance to one of the first-line campylobacteriosis treatments is of concern, especially considering the 
immune status of the patient, and may have contributed to the initial persistence of the bacterial population.
The erythromycin resistance of these isolates was dynamic: all cases of resistance were shown to be caused 
by non-synonymous point mutations in the peptidyl-encoding region of domain V of the 23 S rRNA gene, of 
which C. jejuni carries three copies24. Initially, high level resistance appeared once in isolate 236126 in January 
2002, the result of a 2075 A > G mutation in three gene copies. This mutation, the most commonly found in 
Campylobacter44,45, is known to produce high level, stable resistance44–46, but was not maintained in this popu-
lation. The isolates remain sensitive until a 2074 A > C mutation arises sometime between March 2011 and July 
2012. This mutation is present in all three copies of the 23 S rRNA gene and leads to high-level resistance to eryth-
romycin, again consistent with previous literature47. The mutation was not observed in two of the three gene cop-
ies at some point between July 2012 and May 2014, resulting in variable levels of resistance in subsequent isolates. 
Although information on the specific antibiotic regime of the patient referred to in this study was not available, 
it is possible that this change in resistance genotype could be a result of cessation of macrolide treatment leading 
to a lack of selective pressure, or, perhaps more likely, instead be due to the fitness cost that is exerted on C. jejuni 
strains carrying mutations in the 23 S rRNA gene, as observed by other studies47,48.
The lower MIC values seen in those isolates with a single mutated copy of the 23 S rRNA gene were consistent 
with previous findings that fewer than three mutations lead to lower MIC values45,49. Both studies also report that 
macrolide resistance was not found at all in Campylobacter isolates with only one mutated copy of the gene; how-
ever, our findings show that low level resistance to erythromycin is possible when just a single copy of the gene 
carries a mutation in the macrolide binding site. This effect appears to be variable, perhaps due to compensation 
by the remaining two wild-type ribosomal genes. It is also possible that the mutation is present unevenly within 
the bacterial population, or is rapidly lost during culture due to fitness costs of maintaining the polymorphism, 
and therefore different results are produced depending upon the colony chosen for phenotypic testing. Isolate 
85702, which had two separate colonies archived at the time of receipt, provides evidence towards this theory, 
as one was found to be resistant and the other susceptible, despite deriving from the same sample. Additionally, 
isolates 74288 and 74289, which were collected on the same day, show a large difference in their MIC values. 
The presence of the single mutation, while not necessarily leading to resistance, may be a way for the bacteria to 
maintain the resistance mutation whilst negating the fitness costs associated with multiple copies of the mutation, 
making it easier to gain high-level, stable resistance by accumulating further mutations.
conclusion
This study is among the first to examine the microevolution of a long-term campylobacteriosis infection in an 
immunocompromised human host. This unique situation – a natural experiment involving the colonisation of a 
single clone followed by evolution, with no subsequent infections and no lateral gene transfer – allowed obser-
vation of evolutionary processes that may otherwise occur on a far greater timescale, and an insight into the 
potential beginnings of host adaptation and genome degradation. The contemporaneous sequencing and analysis 
of isolates from chronic infections is an important step forward in public health microbiology. By tracking the 
evolution of a strain, we can potentially inform clinical decisions such as antibiotic treatment in real-time, when 
mutations arise, and ultimately aim to reduce the length of disease in cases of chronic infection such as the one 
presented here.
Methods
Bacterial isolates. Public Health England (PHE) received a total of 25 C. jejuni isolates (Table 2) over the 
course of 15 years, derived from single colonies from stool samples belonging to a patient with CVID with symp-
toms of persistent diarrhoea. From 2001 until 2015, these isolates were typed using serotyping and/or phage 
typing. In 2015, 7-gene multilocus sequence typing (MLST)50,51 was introduced at PHE, and from January 2015 
onwards the isolates underwent routine whole genome sequencing (WGS) upon receipt. For the purpose of this 
study, all viable isolates from the archive were genome sequenced (n = 23). Isolates were retrieved from −80 °C 
storage on beads and regrown on Columbia Blood Agar (CBA) media at 37 °C under microaerobic conditions 
for 48–72 hours.
Two isolates could not be regrown and so WGS data and repeat antimicrobial susceptibility results are not 
available for these isolates. Isolate 18857 was received on the same day as isolate U2. Isolates 74288 and 74289 
were also both received on the same day. Isolate 85702 was archived twice. Two of the previously sequenced iso-
lates from 2014 and 2015 (56946 and 106535 respectively) could not be regrown and therefore were not available 
for phenotypic antimicrobial susceptibility testing.
Antimicrobial susceptibility testing. Antimicrobial susceptibility was determined using agar dilution 
methodology and interpreted according to the European Committee on Antimicrobial Susceptibility Testing 
(EUCAST) clinical breakpoints or epidemiological cut-offs52 (Supplementary Table S6). Sixteen of the isolates 
were originally tested for antimicrobial susceptibility upon receipt, though the panel of antimicrobials varied over 
the years. Isolates U1 and 106535, which could not be regrown, were both described in the laboratory database 
as being resistant to ciprofloxacin upon initial receipt, although the minimum inhibitory concentration (MIC) 
value was not noted.
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DNA extraction and whole genome sequencing. Following overnight culture on CBA media, isolates 
were inoculated into Brain Heart Infusion broth and lysed using tissue lysis buffer, proteinase K and RNase A 
(Qiagen QIAsymphony DNA Mini Kit). Genomic DNA from the cell lysates was extracted using a QIAsymphony 
automated DNA extraction system (Qiagen). Libraries were prepared using the Illumina Nextera XT kit and 
sequenced using an Illumina HiSeq. 2500 in rapid run mode, producing 100 bp paired-end reads (Supplementary 
Table S7).
Bioinformatic analyses. The PHE bioinformatics pipeline characterises sequence types using MOST53 with 
allelic profiles derived from the PubMLST Campylobacter database54. Antimicrobial resistance determinants are 
identified by mapping reads to known resistance genes, as described in Swift et al.55, and genome assembly is 
performed using SPAdes56 (assembly statistics available in Supplementary Table S7). Parsnp from the Harvest 
software suite57 was used to generate core genome SNP alignments and subsequent phylogenies using FastTree 
258 from the assembled genomes, and Snippy59 was used to match mutations to reference genes. A check for 
recombination was performed using Gubbins60. Root-to-tip linear regression was performed using TempEst soft-
ware61. Ribosomal21 and core genome MLST23 analyses were performed using the Genome Comparator function 
of BIGSdb54,62, and the PubMLST Campylobacter database was queried to identify closely related isolates. Core 
genome SNP alignments produced by Parsnp were analysed using the BEAST v.2.4.4 package63 to estimate muta-
tion rates, with tip dates specified as each isolate’s year of isolation. Following model testing using jModelTest264 
the HKY model of nucleotide substitution with equal base frequencies in order to simulate the K80 model was 
identified as the best substitution model for these data. A strict molecular clock as per the results of the root-to-tip 
linear regression was selected, starting with an estimated clock.rate of 2.92e−6, using the coalescent constant pop-
ulation model. Five independent Markov Chain Monte Carlo (MCMC) chains were run, each with a 1 million 
burn-in and 9 million chain length, sampled every 10,000 states.
ethics approval. This study was exempted from requiring ethical approval following internal review by 
Public Health England.
Isolate
Isolation 
Date HS PT ST AST WGS
236124 2001-09 37 2 45 ✓ ✓
236125 2001-11 Untypable 2 45 ✓ ✓
236126 2002-01 Untypable 2 45 ✓ ✓
236127 2002-03 12 2 45 ✓ ✓
236128 2002-07 13 2 45 ✓ ✓
236129 2002-09 13 2 45 ✓ ✓
236130 2002-10 13 2 45 ✓ ✓
236131 2002-11 13 2 45 ✓ ✓
236132 2003-04 13 2 45 ✓ ✓
236133 2003-09 Untypable 2 45 ✓ ✓
236123 2004-02 37 2 45 ✓ ✓
236134 2005-01 12 2 45 ✓ ✓
236136 2011-03 12 2 45 ✓ ✓
U1 2011-04 10/12 2 ×b ×b ×b
236137 2012-07 12 2 45 ✓ ✓
U2 2014-05 ND 2 ×b ×b ×b
18857 2014-05 ND 2 7334 ✓ ✓
236139 2014-08 ND 2 45 ✓ ✓
56946 2014-09 ND ND 45 ×c ✓d
74288 2014-12 ND ND 45 ✓ ✓
74289 2014-12 ND ND 45 ✓ ✓
85702 2015-01 ND ND 45 ✓✓e ✓
106535 2015-04 ND ND 45 ×c ✓
201487 2015-12 ND ND 45 ✓ ✓
216332 2016-01 ND ND 45 ✓ ✓
Table 2. Summary of 25 C. jejuni isolates received over 15 year period from this patient; information provided 
by routine method of testing in use at time of receipt. aDate of isolation unknown; shown instead is the date the 
isolate was received. bNo sequencing data available. cOriginally sequenced upon receipt but could not be revived 
for the enhanced antimicrobial susceptibility testing. dContaminated genome sequence, isolate not included 
in genomic analysis. eAntimicrobial Susceptibility Testing (AST) performed twice on separate archived copies 
of isolate. Isolate 106535 has limited information on AST results from the original testing. Heat-stable antigen, 
serotype; HS, Penner serotype; PT, phage type; ST, sequence type; AST, antimicrobial susceptibility testing; 
WGS, whole genome sequencing; ND, not done.
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Data availability
The sequences produced during this study are available in the NCBI Sequence Read Archive repository 
under BioProject PRJNA505131. The individual accession numbers are provided in Supplementary Table S7. 
Additionally, all genomes are available in the PubMLST Campylobacter database (available at: pubmlst.org/
campylobacter), with PubMLST ID numbers also provided in Supplementary Table S7.
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